NOMAD POWER SOLUTIONS, INC. Cash and Cash Equivalents
NOMAD POWER SOLUTIONS, INC. (NMAD) had Cash and Cash Equivalents of $3.41 million as of 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2024-05-09
- 2024-03-31: Cash and Cash Equivalents, at Carrying Value $3.41M.
- 2023-12-31: Cash and Cash Equivalents, at Carrying Value $4.20M.
- 2023-09-30: Cash and Cash Equivalents, at Carrying Value $5.11M.
- 2023-06-30: Cash and Cash Equivalents, at Carrying Value $2.91M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2024-03-31 | $3.41M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $4.20M 10-Q · filed 2024-05-09 |
| 2023-09-30 | $5.11M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $2.91M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $4.09M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $5.35M 10-K · filed 2024-03-19 |
| 2022-09-30 | $6.56M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $7.74M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $3.78M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $4.82M 10-K · filed 2023-03-29 |
| 2021-09-30 | $5.96M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $6.80M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $7.74M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $5.07M 10-K · filed 2022-03-21 |
| 2020-09-30 | $1.08M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $1.77M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $2.18M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $2.60M 10-K · filed 2021-03-26 |
| 2019-09-30 | $2.98M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $3.56M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $3.89M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $4.27M 10-K · filed 2020-03-25 |
| 2018-09-30 | $374.36K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $536.00K 10-Q · filed 2018-08-02 |
| 2018-03-31 | $808.04K 10-Q · filed 2019-05-09 |
| 2017-12-31 | $1.31M 10-Q · filed 2019-05-09 |
| 2017-09-30 | $1.59M 10-Q · filed 2018-11-08 |
| 2017-06-30 | $2.03M 10-Q · filed 2018-08-02 |
| 2017-03-31 | $870.94K 10-Q · filed 2018-04-27 |
| 2016-12-31 | $199.93K 10-K · filed 2019-03-25 |
| 2016-09-30 | $669.77K 10-Q · filed 2017-11-09 |
| 2016-06-30 | $95.78K 10-Q · filed 2017-08-04 |
| 2016-03-31 | $99.39K 10-Q · filed 2017-05-10 |
| 2015-12-31 | $25.28K 10-K · filed 2018-03-23 |
| 2015-09-30 | $217.56K 10-Q · filed 2016-11-04 |
| 2015-06-30 | $126.52K 10-Q · filed 2016-08-10 |
| 2015-03-31 | $140.10K 10-Q · filed 2016-05-06 |
| 2014-12-31 | $44.41K 10-K · filed 2017-03-29 |
| 2014-09-30 | $8.86K 10-Q · filed 2015-11-10 |
| 2014-06-30 | $46.72K 10-Q · filed 2015-08-07 |
| 2014-03-31 | $115.44K 10-Q · filed 2015-05-13 |
| 2013-12-31 | $475.02K 10-K · filed 2016-03-28 |
| 2012-12-31 | $1.66M 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |